Home COVID 19 Founder Traces Dr Batra’s Journey In New Book
COVID 19Latest NewsSpotlight

Founder Traces Dr Batra’s Journey In New Book

Share
Share

Dr. Mukesh Batra, the founder of Dr. Batra’s chain of homeopathy clinics, traces his journey as well as his company’s in his part memoir-part guidebook.

According to its publishers HarperCollins India, “The Nation’s Homeopath: How Dr. Batra’s Became the World’s Largest Chain of Homeopathy Clinics” is an unusual tale of entrepreneurship, risk appetite, resilience, and self-belief.

From humble beginnings with a clinic in Chowpatty, Bombay in 1982, Dr. Mukesh Batra, son of a homeopath and his allopathic doctor wife, now manages over 200 clinics in seven countries and in 150 cities of India.

When loans were not readily available in the early 80s, Dr. Mukesh Batra borrowed money at a staggering interest rate of 36 percent per annum. And since then, he has been leading an exciting life.

Dr. Mukesh Batra is a Padma Shri recipient and has treated celebrities, including presidents, prime ministers, actors, sportsmen, artists, among others, as well as the common man for decades. In this journey, he has also challenged death multiple times, has known love and heartache, and has experienced failures too in some business ventures.

Well, he says, “The Nation’s Homeopath” is the story of “my personal experiences as a medical professional and an entrepreneur. The reader will get a ringside seat of the mistakes I’ve made and how I converted challenges into opportunities and failures into success.”

In the book, he also mentions how Dr. Batra’s focused on 4Cs – communication, continuity, cost-cutting, and compassion – to deal with the challenges posed by Covid. He says if cancer is the big C, so is Covid.

“And we focused on 4Cs to deal with this C. Communication was one. We kept talking to employees and patients. Continuity was another – as much as possible we saw to it that there was no break in treatments. The third ‘C’ was cost-cutting. Compassion was the last ‘C’,” he says.

Sachin Sharma, the senior commissioning editor at HarperCollins India, describes the book as a “thoroughly gripping read, that is honest, witty and a guide for the budding entrepreneur”.

Spelling out some challenges during the pandemic, Dr. Mukesh Batra writes, “The supply chain and market disruption during Covid, together with a reduction in the sales team and health advisers, meant that unsold goods over a few months were lying in the market. This meant going to each of the 200 distributors and agreeing to change unsold stock with fast-moving products. This led to further financial losses which were not anticipated.”

But through all the problems, he said he continued to innovate.

“We launched new products, some of them necessitated by a coronavirus, like alcohol-based hand sanitizers… This not only increased our product portfolio and excited the marketplace, but also added to our turnover and profitability.”

He also says Dr. Batra’s state-of-the-art clinical management system (CMS) also helped the company to treat patients during the Covid pandemic, as its doctors could use the systems and databases while working from home.

Share

Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Don't Miss

Latest News

How Seasonal Flu Symptoms Are Changing in 2026—and What It Means for You

Seasonal influenza, commonly known as the flu, affects millions of people worldwide every year, and 2026 has already shown changes in how the...

WHO
Press Release

WHO South-East Asia Regional Office building inaugurated

The newly constructed building of the World Health Organization South-East Asia Regional Office in New Delhi, was today inaugurated by the Honourable Prime...

Air Pollution
Health News

Delhi Chokes Under Toxic Air: Schools Shut, Offices Go Work From Home — How to Stay Safe

New Delhi, 23 December, 2025: Delhi once again finds itself gasping for breath as air pollution levels surge to hazardous levels, pushing authorities...

Colorectal cancer
Latest News

Cervical Cancer Awareness Month 2026: Screening Tips Every Woman Should Know

Cervical cancer is one of the most preventable forms of cancer, yet it remains a leading cause of cancer-related deaths among women globally....

Bird Flu
Latest News

Bird Flu Alert: How to Protect Yourself Without Panicking

Bird flu, also known as avian influenza, is a viral infection primarily affecting birds but capable of infecting humans in rare cases. The...

Section title

Related Articles
Latest News

Broken Heart Syndrome Is Real: Doctor Explains Why Emotional Stress Can Trigger Heart Attacks

When we hear the phrase “broken heart,” most of us think of...

COVID
Latest News

Long COVID May Be Triggering Alzheimer’s-Like Changes in the Brain: New Study

A new study suggests that Long COVID—the lingering post-infection condition experienced by...

Cancer
Latest News

Immunotherapy vs Chemotherapy: Which Cancer Treatment Works Better?

Cancer treatment has evolved rapidly over the past few decades, offering patients...

The Nipah virus is considered one of the deadliest zoonotic infections globally, not because it spreads rapidly like influenza or COVID-19, but because of its extremely high fatality rate, rapid progression, and severe brain involvement. Medical experts warn that once symptoms escalate, the disease can turn fatal within days. According to available data, the case fatality rate of Nipah virus ranges between 50 and 75 per cent, placing it among the most lethal viral infections known to humans. In this explainer, Dr Dip Narayan Mukherjee, Consultant – Microbiology and Infectious Diseases, CK Birla Hospitals, CMRI, sheds light on why the virus is so dangerous and difficult to control. Why Is the Nipah Virus So Deadly? According to Dr Mukherjee, Nipah’s lethality lies in a combination of delayed symptom recognition, aggressive disease progression, and early involvement of the brain. “Nipah virus often begins with very non-specific symptoms, which makes early detection difficult. By the time it is clinically suspected, the virus may have already affected the brain,” he explains. Early Symptoms Often Go Unnoticed One of the biggest challenges in controlling Nipah virus is that its initial symptoms closely resemble common viral illnesses, leading to delays in diagnosis and isolation. Early symptoms include: Fever Headache Cough Muscle pain General weakness “These symptoms are easily mistaken for flu, viral fever, or respiratory infections,” says Dr Mukherjee. “This delay gives the virus time to progress silently.” Severe Brain Infection Drives High Mortality The most dangerous aspect of Nipah virus infection is its neurological involvement. The virus frequently causes encephalitis, or inflammation of the brain, which significantly increases the risk of death. Neurological symptoms may include: Seizures Confusion and altered consciousness Extreme drowsiness Coma “Once the central nervous system is involved, the disease becomes very difficult to manage,” Dr Mukherjee notes. “At this stage, treatment is largely supportive because there is no specific antiviral therapy available.” This lack of targeted treatment options makes early detection critical. Human-to-Human Transmission Raises Risk While Nipah virus is primarily transmitted from fruit bats, it can also spread from person to person, particularly in healthcare settings. Dr Mukherjee points out that: Caregivers and healthcare workers are at higher risk Exposure to high viral loads can worsen outcomes Inadequate infection control increases transmission risk “Strict adherence to infection control practices is essential. Even a small lapse can result in secondary infections,” he says. Zoonotic Nature Makes Exposure Hard to Predict Nipah virus is transmitted from fruit bats, either directly or through intermediate hosts such as pigs. This zoonotic pattern makes outbreaks unpredictable, especially in regions where humans, animals, and wildlife interact closely. Adding to the challenge: There is no approved vaccine Treatment options remain limited Isolation protocols must be strictly enforced What Can Reduce Nipah Fatalities? According to experts, early action remains the most effective defence against Nipah virus. Key measures include: Early isolation of suspected cases Strict use of personal protective equipment (PPE) Rapid escalation and referral to specialised centres Strong hospital infection control protocols “The earlier the virus is identified and contained, the better the chances of preventing severe disease and fatalities,” Dr Mukherjee emphasises. The Bottom Line Nipah virus continues to be a serious public health threat because of its high fatality rate, neurological complications, and lack of targeted treatment. Its ability to masquerade as a mild illness in the early stages makes vigilance crucial. Health experts stress that awareness, early suspicion, and strict infection control are currently the most powerful tools to reduce deaths linked to this deadly virus. As Dr Mukherjee concludes, “With Nipah, time is the most critical factor. Early recognition can save lives.”
Latest News

Why Nipah Virus Has a High Fatality Rate: Factors Affecting Disease Severity

The Nipah virus is widely regarded as one of the deadliest zoonotic...

×